Nestle SA/ CH0038863350 /
2024-11-12 5:31:45 PM | Chg. -1.12 | Volume | Bid5:31:45 PM | Ask5:31:45 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
77.98CHF | -1.42% | 836,294 Turnover: 65.34 mill. |
-Bid Size: - | -Ask Size: - | 208.26 bill.CHF | 3.85% | 18.40 |
GlobeNewswire
08-13
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
08-06
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
07-23
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
06-12
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06-06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
05-08
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
03-26
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
03-19
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...